TABLE 1.
Variable | Category | Total interview sample (N = 40) |
---|---|---|
Age, n (%) | 18–24 years old | 5 (12) |
25–44 years old | 17 (43) | |
45–64 years old | 13 (33) | |
65 years and older | 5 (13) | |
Gender, n (%) | Women | 31 (78) |
Men | 7 (18) | |
Genderqueer/gender non‐binary, transgender person | 2 (5) | |
Race a , n (%) | White | 27 (68) |
Black or African American | 9 (23) | |
American Indian or Alaskan Native | 4 (10) | |
Asian | 3 (8) | |
Native Hawaiian or Other Pacific Islander | 1 (3) | |
Other b | 1 (3) | |
Prefer not to answer | 1 (3) | |
Ethnicity, n (%) | Hispanic | 9 (23) |
Non‐Hispanic | 31 (78) | |
Relationship status, n (%) | Married or partnered | 19 (48) |
Not married or partnered | 21 (53) | |
# of other adults in household, n (%) | None | 8 (20) |
1–2 | 27 (68) | |
3–4 | 5 (13) | |
# of children in household, n (%) | None | 12 (65) |
1 | 5 (13) | |
2 or more | 9 (23) | |
Education, n (%) | Grade 12 or GED equivalent | 3 (8) |
Associates degree, technical school, or trade apprenticeship; some college (no degree awarded) | 18 (45) | |
College degree or advance degree | 19 (48) | |
Employment a , n (%) | Paid employment | 22 (55) |
Student | 8 (20) | |
Homemaker | 3 (8) | |
Retired | 6 (15) | |
Unemployed | 2 (5) | |
Disabled (disability or leave of absence for any reason) | 10 (25) | |
Other | 1 (3) | |
Household income, n (%) | Under $22,000 | 8 (20) |
$22,000 to $49,999 | 10 (25) | |
$50,000 to $99,999 | 10 (25) | |
$100,000 and over | 8 (20) | |
Prefer not to answer | 4 (10) | |
Migraine subtype by frequency, n (%) | <15 headache days per month on average (episodic migraine c ) | 20 (50) |
≥15 headache days per month on average (chronic migraine c ) | 20 (50) | |
Average number of headache days per month, n (%) | 0–1 | 0 |
2–3 | 6 (15) | |
4–7 | 8 (20) | |
8–14 | 6 (15) | |
15–23 | 18 (45) | |
24 or more | 2 (5) | |
OTC or prescription acute pharmacologic treatment (within past year), n (%) | Yes | 40 (100) |
Current preventive pharmacologic treatment, n (%) | Yes | 35 (88) |
No | 5 (13) |
Abbreviations: ICHD‐3 CM, International Classification of Headache Disorders 3rd edition, chronic migraine; OTC, over the counter.
Total percent exceeds 100 because participants were able to select more than one race and/or employment status category.
Respondent reported races of “White, South American, and North African” and chose the label “other.”
Chronic migraine was defined as an average monthly headache day frequency of ≥15 per month among people who meet criteria for migraine as per Silberstein‐Lipton criteria and episodic migraine was the corollary. 25 It was not possible to assess the ICHD‐3 CM criterion of ≥8 migraine days per month in this single visit study, which did not include a diary. Percentages ending in ≥0.5 were rounded up to the next whole number.